Our Board
Members of the Board
Emelie Antoni, AstraZeneca AB (ordförande)
Jakob Tellgren, Merck Sharp & Dohme (Sweden) AB (vice ordf.)
Anders Wesslau, Merck AB
Anja Schwarz, Haleon Sweden AB
Björn Berglund, Swedish Orphan Biovitrum AB
Johan Kahlström, Novartis Sverige AB
José Daniel Lucas, Eli Lilly Sweden AB
Jörg Schulze, Bristol Meyers Squibb AB
Karin Eidolf, Bayer AB
Karin Järperud, Amgen AB
Malin Parkler, Pfizer AB
Olav Fromm, Chiesi Pharma AB
Per Öhlén, Sanofi AB
Vatroslav Mateljic, Takeda Pharma AB
Administrative director
Karolina Antonov, Lif
Secretary
Sophia Brodin, Lif
Legal representative
Linda Melkersson, Jurist, Lif
Updated: 19 September 2023